GENERAL INFORMATION FOLLOWED BY A TENTATIVE STATEMENT OF WORK NOTICE: This is not a solicitation but rather a Request for Information (RFI) (Sources Sought) to determine capability of potential sources and is for information and planning purposes only. Veterans Health Affairs, Network Contracting Office 4, is issuing this request for information/sources sought notice in order to identify capable small business firms to perform services for the Lebanon VA Medical Center, 1700 South Lincoln Avenue, Lebanon PA 17042. Responses must be submitted by 2:00 PM (EST) April 26, 2017. Submit responses to the information requested above via email to [email protected] . All SDVOSB and VOSB firms that respond shall include proof of CVE certification via www.vip.vetbiz.gov. All small business firms that respond shall include proof of small business status via their Representations and Certifications in accordance with (FAR 4.1102 Policy). While SDVOSB/VOSB contractors are preferred, all capable contractors are welcome to respond to this sources sought notice for market research purposes, and shall include as part of their response a brief capability statement that covers the information in the following tentative statement of work The results of this market research will assist in the development of (1) the requirement, and (2) the acquisition strategy (e.g., socioeconomic set-aside, full and open competition, etc.). VA assumes no responsibility for any costs incurred associated with the preparation of responses. SAMPLE STATEMENT OF WORK Lebanon VA Medical Center Specialized Services and Testing For Anatomic Pathology and Cytology Specimens Contractor shall provide all employees, supervision, supplies and equipment necessary to perform specialized services for Anatomic Pathology specimens to include Immunohistochemistry Stains, Cytochemical Stains, Flow Cytometry, FISH testing, Cancer Marker Testing and other estoteric testing for the Lebanon VA Medical Center, 1700 South Lincoln Avenue, Lebanon PA 17042. The term of this contract shall begin on 07/01/2017 to 06/30/2018(Base) to prevent any interruptions of service and will include (4) option years to end on 06/30/2022. The LVAMC will package specimens according to the guidelines required by the contractor. Contractor shall provide all necessary supplies for biomedical materials to be transported from the VA Medical Center Laboratory to the Contractor s laboratory. These supplies shall include, but may not be limited to: Shipping and packaging containers. Packing material must be capable of maintaining temperature requirements for specimens until they reach the Contractor s laboratory. Required labels and packaging materials for shipping specimens via courier that are infectious, or etiologic agents, in accordance with appropriate requirements of 49 CFR Part 72, CFR Parts 171 and 173, and the Dangerous Goods Regulations of the International Air Transport Association (IATA) consistent with current regulatory updates. Specimens will be sent along with a copy of the VA Standard Form 515, which will contain all the patient and specimen information. Contractor must ensure the security of the specimen contains and protect against the accessibility of the specimens and the information that accompanies the specimens. Routine transportation services shall occur once per day, Monday Friday, except for Federal Holidays. Specimen pick-up times will be late afternoon between 5PM 6PM. Vendor may transport specimens by courier or via FED-X/ UPS. If using FED-X or UPS, the vendor will supply pre-paid envelopes for shipping specimens. Pick-up of specimens will be from the Main Laboratory, currently located on Ground Floor, Building 1, Room 3. Location of the Main Laboratory may change. Pick-up location will change with any moves of the laboratory. All Blocks or slides will be returned to the LVAMC located at 1700 South Lincoln Avenue, Lebanon PA, 17042, Attention: Pathology & Laboratory Medicine (713) via courier drop-off or UPS or FEDX. These materials shall be returned within 7 days after final diagnosis is reported. Contractor must provide a phone number for consultation Pathology services regarding test results. Services will be minimally Monday through Friday, excluding Federal Holidays, 9AM 5PM. Contractor test reports must contain the following information at a minimum: Patient s full name Patient s identification number (e.g. social security number) Physician s name VA Laboratory accession number Submitting Laboratory Name (VA Medical Center, Lebanon) Submitting facility account number Patient s location (clinic/ ward) Tests(s) ordered Date/ time of specimen collection Date/ time test completed Test result Reference intervals (if applicable adjusted for age, sex or race) Interpretation of Results if applicable Name and address of testing laboratory Any other information the laboratory has that may indicate a questionable validity of test results Specimen inadequacy shall be reported with documentation supporting its unsuitability for testing. Hard copy Reports should be sent with a courier or alternately faxed to 717-228-5962. Results will be available within the listed turnaround times. Turnaround time will be from the time the specimen leaves the Lebanon VAMC Laboratory Test Name Turnaround Time Flow Cytometry 3 Days Morphology 5 Days FISH 6 Days Cytogenetics 8 Days Molecular 8 Days The Contractor shall provide the name(s) and telephone number(s) of contractor employees who will address the following customer services throughout the contract performance period: Routine questions and clarifications regarding collection requirements Inquiries regarding the status of pending orders Result interpretation inquires/ Consultative services Inquiries regarding supplies Contractor shall be reimbursed per technical component, professional component or Global component, of the applicable CPT code, depending on the services rendered. CPT codes will include with the projected annual volumes of each: TEST_NAME CPT Sum Of TOTAL QUANTITY Microsatellite Instability, MSI 81301 3 Microdissection - Global 88381 6 EGFR Mutation Analysis, NSCLC 81235 2 KRAS Mutation, CRC 81275 4 MYD88 Mutation Detection PCR 81479 2 Comprehensive BRCA1/2 Analysis 81162 2 BCR-ABL1, CML/ALL, PCR, Quant 81206; 81207 40 JAK2 V617F, Quantitative 81270 4 BRAF Gene Mutation Analysis 81210;88381 12 KRAS Extended Analysis 81210;88381 8 BRAF Analysis, Melanoma 81210;88381 6 NRAS Extended Analysis 81311;81479;88381 4 JAK2 Exon 12 Mutation Analysis 81403 8 Reveal (R) SNP CMA - Oncology 81406 2 Microsatellite Instability 81301;88381 2 Chromosome Analysis, Blood 88230; 88262 2 Chromosome Analysis, BM 88237;88264 60 EGFR Mutations 81235;88381 4 Chromosome, Leukemic Blood 88237; 88264 8 Handling/Conveyance of Spec 99001 15 HER2 IHC 88360 8 ER/PR 88360x2 2 JAK2 V617F Mutation Detection 81270 70 KRAS Mutation Analysis, CRC 81275 4 Flow Tissue/Fluid 88184; 88185x18; 88189 30 Flow Tissue/Fluid 8 Color 88184; 88185x23; 88189 62 Flow Cytometry PNH FLAER 88184; 88185x7; 88187 2 Consult EGL Slides 88323 60 Flow Cyto Interp (2-8 Markers) 88187 10 Flow Cyto Interp (9-15 Marker) 88188 6 Flow Comprehensive Screening 88184; 88185x23; 88189 4 Flow Plasma Cell 88184; 88185x16; 88189 26 ALK by FISH (NSCLC) 88271x2; 88274 6 ROS1 Oncology FISH 88271x2; 88275 6 EGFR FISH 88271 (x2) 88274 2 IHC 1st AB & 2 Addtl AB Global 88342; 88341 x2 4 IHC 1st AB & 3 Addtl AB Global 88342; 88341 x3 50 HPV Subtype Panel 88365; 88364x2 2 IHC 1st Antibody Global 88342 2 HER2 by FISH 88377 8 Pathology Review 88305 120 Pathology Review 88305 2 Flow Cytometry, First Marker 88184 16 Flow Cytometry, Ea Add Marker 88185 50 Flow Cytometry, Ea Add Marker 88185 50 Flow Cytometry, Ea Add Marker 88185 50 Flow Cytometry, Ea Add Marker 88185 50 Flow Cytometry, Ea Add Marker 88185 50 Flow Cytometry, Ea Add Marker 88185 50 Flow Cytometry, Ea Add Marker 88185 32 Flow Cytometry, Ea Add Marker 88185 8 Flow Cytometry, Ea Add Marker 88185 6 Flow Cytometry, Ea Add Marker 88185 6 Flow Cytometry, Ea Add Marker 88185 6 Flow Cytometry, Ea Add Marker 88185 6 IHC ea addl AB Stain x1 GLBL 88341 50 IHC ea addl AB Stain x1 GLBL 88341 50 IHC ea addl AB Stain x1 GLBL 88341 50 IHC ea addl AB Stain x1 GLBL 88341 50 IHC ea addl AB Stain x1 GLBL 88341 50 IHC ea addl AB Stain x1 GLBL 88341 30 IHC ea addl AB Stain x1 GLBL 88341 15 IHC ea addl AB Stain x1 GLBL 88341 10 IHC ea addl AB Stain x1 GLBL 88341 10 IHC ea addl AB Stain x1 GLBL 88341 8 IHC ea addl AB Stain x1 GLBL 88341 4 IHC ea addl AB Stain x1 GLBL 88341 4 IHC ea addl AB Stain x1 GLBL 88341 2 IHC ea addl AB Stain x1 GLBL 88341 2 IHC Prog/Pred TS/EGFR/p27/p53 88360 26 IHC Prog/Pred TS/EGFR/p27/p53 88360 10 Special Stains - Group II 88313 175 Special Stains - Group II 88313 100 Special Stains - Group II 88313 4 Decalcification 88311 40 ISH, 1st probe GLBL 88365 14 ISH each addtl probe x1 GLBL 88364 16 CLL FISH Panel #N/A 2 Bone Marrow Smear Interp 85097 60 IHC 1st AB Stain x1 PROF 88342-26 2 IHC ea addl AB Stain x3 PROF 88341-26x3 2 Spec Stain: GP II X1 Tech 88313-TC 2 IHC 1st AB Stain x1 TECH 88342-TC 2 IHC ea addl AB Stain x3 TECH 88341-TCx3 2 IHC 1st Antibody - TECH ONLY 88342-TC 100 IHC each Addtl AB - TECH ONLY 88341-TC 100 IHC each Addtl AB - TECH ONLY 88341-TC 70 IHC each Addtl AB - TECH ONLY 88341-TC 60 IHC each Addtl AB - TECH ONLY 88341-TC 40 IHC each Addtl AB - TECH ONLY 88341-TC 32 IHC each Addtl AB - TECH ONLY 88341-TC 22 IHC each Addtl AB - TECH ONLY 88341-TC 20 IHC each Addtl AB - TECH ONLY 88341-TC 10 IHC each Addtl AB - TECH ONLY 88341-TC 6 IHC each Addtl AB - TECH ONLY 88341-TC 4 IHC each Addtl AB - TECH ONLY 88341-TC 2 IHC each Addtl AB - TECH ONLY 88341-TC 2 Special Stains-Group II TC 88313-TC 6 Spec-Stain,GRP I-Micro 1st 88312-TC 2 Spec-Stain,GRP I-Micro 2nd 88312-TC 2 ISH 1st Probe TECH Only 88365-TC 4 ISH Addtl Probe TECH Only 88364-TC 4 ISH Addtl Probe TECH Only 88364-TC 2 IHC 1st TECH-PP 88341-TCx1 4 IHC ea Addl Single - TECH PP 88341-TCx1 15 FISH DNA Probe X2 88271 15 FISH DNA Probe X3 88271 8 FISH DNA Probe X4 88271 15 FISH DNA Probe X6 88271 30 FISH DNA Probe X8 88271 2 FISH DNA Probe X10 88271 16 FISH analyze 25-99 cells x1 88274 2 FISH analyze 25-99 cells x2 88274 8 FISH analyze 100-300 cells x1 88275 15 FISH Analyze 100-300 cells X3 88275 26 FISH analyze 100-300 cells x4 88275 15 FISH analyze 100-300 cells x5 88275 2 FISH analyze 100-300 cells x6 88275 2 FISH analyze 100-300 cells x7 88275 14 PD-L1 by IHC (Keytruda (R)) 88342 4 Quality Assurance Monitoring Contractor must have and maintain licensure and certifications required to operate its laboratory. Monitoring of contractor s performance shall be demonstrated through clinical and administrative record reviews. Services will be monitored through one or a combination of the following mechanisms: Surgical Pathology/ Cytology Department will monitor Contractor performance to ensure that services called for in the contract have been received by VA in a timely manner. Services such as: Specimen pick-up is minimally daily and not earlier than 5PM. Compliance rate for this is minimally 90%. Turn-around times for resulting of tests are at a minimal compliance rate of 90%. Documentation of services performed will be reviewed prior to certifying payment. VA will pay only for services actually provided, and in accordance with the pricing schedule. Quality Factors that will be monitored. PERFORMANCE OBJECTIVE TASKS: PERFORMACE STANDARD ACCEPTABLE (MINIMAL) QUALITY LEVEL MONITORING METHOD Ensure the safety and integrity of specimens No loss or destruction of specimens 100% of the time Contractor reporting; Government inquiries Testing services will be performed in accordance with the defined turnaround times (TAT) Results will be reported within the TAT as stated in the contract 90% of the time 10% of randomly selected tests Pick-up times for specimens are within the designated times +/- 30 min Contractor pick-up specimens with the designated time +/- 30 min 90% of the time Direct Observation

Bid Protests Not Available